Advanced in Hypophosphatemia

Sunil Bhandari

Kingston Upon Hull, ENG, GB 
Advanced in Hypophosphatemia
Kingston Upon Hull, ENG, GB 
OverviewLocationsClinical Research

Overview

Sunil Bhandari practices in Kingston Upon Hull, United Kingdom. Mr. Bhandari is rated as an Advanced expert by MediFind in the treatment of Hypophosphatemia. His top areas of expertise are Iron Deficiency Anemia, Anemia, Chronic Kidney Disease, Kidney Transplant, and Parathyroidectomy.

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Hypophosphatemia.

Gender
Male

Locations

Kingston Upon Hull, ENG, United Kingdom
Other Locations
Birmingham, ENG, United Kingdom
Ridingmill, ENG, United Kingdom
Leicester, ENG, United Kingdom
Nephrology Anlaby Road Hull, East Yorkshire, Anlaby, ENG, United Kingdom
Glasgow, SCT, United Kingdom
Heslington, ENG, United Kingdom
11 Queen Street, Edinburgh, SCT EH21JQ, United Kingdom
York, ENG, United Kingdom
Oxford, ENG, United Kingdom
Castle Hill Hospital, East Yorkshire, Cottingham, ENG, United Kingdom
Wakefield, ENG WF14DG, United Kingdom
Aberdeen, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
Effect of Incremental Introduction of Dialysis Versus Standard Care in Patients With End-stage Renal Disease: a Feasibility Study
Effect of Incremental Introduction of Dialysis Versus Standard Care in Patients With End-stage Renal Disease: a Feasibility Study
Enrollment Status: Completed
Publish Date: April 18, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Randomised Trial of Anti-Cd20 in C4d+ Chronic Allograft Nephropathy
Randomised Trial of Anti-Cd20 in C4d+ Chronic Allograft Nephropathy
Enrollment Status: Completed
Publish Date: March 05, 2020
Intervention Type: Other, Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

186 Total Publications

A Systematic Review Investigates the Safety and Efficacy of Intravenous Iron Dosing in Peritoneal Dialysis.
A Systematic Review Investigates the Safety and Efficacy of Intravenous Iron Dosing in Peritoneal Dialysis.
Journal: British journal of hospital medicine (London, England : 2005)
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bhandari's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile